Understanding why CLL patients stop responding to treatment, and options for salvage therapies
Use of novel algorithms based on pattern recognition to identify patients in need of CLL treatment
Results of trial of venetoclax with bendamustine/rituximab or bendamustine/obinutuzumab in CLL
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.
The stratification of CLL patients and implications for clinical practice